000 01392 a2200373 4500
005 20250515154513.0
264 0 _c20090528
008 200905s 0 0 eng d
022 _a1873-5835
024 7 _a10.1016/j.leukres.2008.11.032
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPunekar, Maqsood
245 0 0 _aT cell function in chronic myeloid leukemia and its treatment with tyrosine kinase inhibitors--clues from and for sarcoidosis.
_h[electronic resource]
260 _bLeukemia research
_cJul 2009
300 _ae91-2 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aFemale
650 0 4 _aFusion Proteins, bcr-abl
_xgenetics
650 0 4 _aHumans
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aProtein Kinase Inhibitors
_xtherapeutic use
650 0 4 _aProtein-Tyrosine Kinases
_xantagonists & inhibitors
650 0 4 _aPyrimidines
_xtherapeutic use
650 0 4 _aSarcoidosis, Pulmonary
_xdiagnosis
650 0 4 _aT-Lymphocytes
_xphysiology
650 0 4 _aTreatment Outcome
700 1 _aThachil, Jecko
700 1 _aSalim, Rahuman
700 1 _aWatmough, Sara
700 1 _aClark, Richard E
773 0 _tLeukemia research
_gvol. 33
_gno. 7
_gp. e91-2
856 4 0 _uhttps://doi.org/10.1016/j.leukres.2008.11.032
_zAvailable from publisher's website
999 _c18600294
_d18600294